Intraoperative beta- detecting probe for radio-guided surgery of brain tumors

G. Baroni, F. Bellini, V. Bocci, F. Collamati, M. Cremonesi, E. De Lucia, R. Faccini, P. Ferroli, S. Fiore, F. Fioroni, C. M. Grana, E. Grassi, M. Iori, M. Marafini, I. Mattei, S. Morganti, G. Paganelli, V. Patera, A. Pepe, L. PiersantiL. Recchia, A. Russomando, A. Sarti, A. Sciubba, M. Schiariti, E. Solfaroli Camillocci, A. Versari, C. Voena

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

The innovation of the radio-guided surgery exploiting β- emitters is the higher tumor-to-non-tumor ratio (TNR) allowing both a smaller radiopharmaceutical absorbed dose to detect cancerous remnants and the possibility of extending the technique also to cases with a large uptake of surrounding healthy organs, as for brain tumors. Our first study cases are meningiomas, since an appropriate β- emitting drug is already available (90Y-DOTATOC), but the goal is to apply this technique to gliomas. We verified the uptake of the radiotracer in 8/10 patients affected by meningiomas with TNR ≥ 10 and in 9/12 patients with a TNR ≥ 4 in case of gliomas. We developed prototypes of an intraoperative probe detecting β- radiation. The core of the probe is a millimetric scintillator made of para-terphenyl due to its high light yield and low density. Tests in laboratory showed that with a radiotracer activity on the tumor of 5 kBq/ml and a TNR of 10 a 0.1 ml cancerous residual can be detected in 1s. That corresponds to administer to the patient 1 MBq/kg of radiopharmaceutical, which is a dose comparable to those administered for diagnostic use. Finally we estimated with a detailed simulation the exposure of the surgeon resulted in ∼0.1 Sv/h to the whole body and ∼1 Sv/h to the hands, well below the corresponding values for established RGS with gamma radiation.

Original languageEnglish
Title of host publication2014 IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2014
PublisherInstitute of Electrical and Electronics Engineers Inc.
ISBN (Print)9781479960972
DOIs
Publication statusPublished - Mar 10 2016
EventIEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2014 - Seattle, United States
Duration: Nov 8 2014Nov 15 2014

Other

OtherIEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2014
CountryUnited States
CitySeattle
Period11/8/1411/15/14

Fingerprint

Radio
surgery
Brain Neoplasms
brain
tumors
Radiopharmaceuticals
Meningioma
Glioma
probes
surgeons
dosage
terphenyls
Gamma Rays
organs
scintillation counters
Neoplasms
emitters
drugs
Hand
prototypes

ASJC Scopus subject areas

  • Nuclear and High Energy Physics
  • Radiology Nuclear Medicine and imaging

Cite this

Baroni, G., Bellini, F., Bocci, V., Collamati, F., Cremonesi, M., De Lucia, E., ... Voena, C. (2016). Intraoperative beta- detecting probe for radio-guided surgery of brain tumors. In 2014 IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2014 [7430882] Institute of Electrical and Electronics Engineers Inc.. https://doi.org/10.1109/NSSMIC.2014.7430882

Intraoperative beta- detecting probe for radio-guided surgery of brain tumors. / Baroni, G.; Bellini, F.; Bocci, V.; Collamati, F.; Cremonesi, M.; De Lucia, E.; Faccini, R.; Ferroli, P.; Fiore, S.; Fioroni, F.; Grana, C. M.; Grassi, E.; Iori, M.; Marafini, M.; Mattei, I.; Morganti, S.; Paganelli, G.; Patera, V.; Pepe, A.; Piersanti, L.; Recchia, L.; Russomando, A.; Sarti, A.; Sciubba, A.; Schiariti, M.; Camillocci, E. Solfaroli; Versari, A.; Voena, C.

2014 IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2014. Institute of Electrical and Electronics Engineers Inc., 2016. 7430882.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Baroni, G, Bellini, F, Bocci, V, Collamati, F, Cremonesi, M, De Lucia, E, Faccini, R, Ferroli, P, Fiore, S, Fioroni, F, Grana, CM, Grassi, E, Iori, M, Marafini, M, Mattei, I, Morganti, S, Paganelli, G, Patera, V, Pepe, A, Piersanti, L, Recchia, L, Russomando, A, Sarti, A, Sciubba, A, Schiariti, M, Camillocci, ES, Versari, A & Voena, C 2016, Intraoperative beta- detecting probe for radio-guided surgery of brain tumors. in 2014 IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2014., 7430882, Institute of Electrical and Electronics Engineers Inc., IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2014, Seattle, United States, 11/8/14. https://doi.org/10.1109/NSSMIC.2014.7430882
Baroni G, Bellini F, Bocci V, Collamati F, Cremonesi M, De Lucia E et al. Intraoperative beta- detecting probe for radio-guided surgery of brain tumors. In 2014 IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2014. Institute of Electrical and Electronics Engineers Inc. 2016. 7430882 https://doi.org/10.1109/NSSMIC.2014.7430882
Baroni, G. ; Bellini, F. ; Bocci, V. ; Collamati, F. ; Cremonesi, M. ; De Lucia, E. ; Faccini, R. ; Ferroli, P. ; Fiore, S. ; Fioroni, F. ; Grana, C. M. ; Grassi, E. ; Iori, M. ; Marafini, M. ; Mattei, I. ; Morganti, S. ; Paganelli, G. ; Patera, V. ; Pepe, A. ; Piersanti, L. ; Recchia, L. ; Russomando, A. ; Sarti, A. ; Sciubba, A. ; Schiariti, M. ; Camillocci, E. Solfaroli ; Versari, A. ; Voena, C. / Intraoperative beta- detecting probe for radio-guided surgery of brain tumors. 2014 IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2014. Institute of Electrical and Electronics Engineers Inc., 2016.
@inproceedings{fd41db3e2d1143d7a7302247e04c445b,
title = "Intraoperative beta- detecting probe for radio-guided surgery of brain tumors",
abstract = "The innovation of the radio-guided surgery exploiting β- emitters is the higher tumor-to-non-tumor ratio (TNR) allowing both a smaller radiopharmaceutical absorbed dose to detect cancerous remnants and the possibility of extending the technique also to cases with a large uptake of surrounding healthy organs, as for brain tumors. Our first study cases are meningiomas, since an appropriate β- emitting drug is already available (90Y-DOTATOC), but the goal is to apply this technique to gliomas. We verified the uptake of the radiotracer in 8/10 patients affected by meningiomas with TNR ≥ 10 and in 9/12 patients with a TNR ≥ 4 in case of gliomas. We developed prototypes of an intraoperative probe detecting β- radiation. The core of the probe is a millimetric scintillator made of para-terphenyl due to its high light yield and low density. Tests in laboratory showed that with a radiotracer activity on the tumor of 5 kBq/ml and a TNR of 10 a 0.1 ml cancerous residual can be detected in 1s. That corresponds to administer to the patient 1 MBq/kg of radiopharmaceutical, which is a dose comparable to those administered for diagnostic use. Finally we estimated with a detailed simulation the exposure of the surgeon resulted in ∼0.1 Sv/h to the whole body and ∼1 Sv/h to the hands, well below the corresponding values for established RGS with gamma radiation.",
author = "G. Baroni and F. Bellini and V. Bocci and F. Collamati and M. Cremonesi and {De Lucia}, E. and R. Faccini and P. Ferroli and S. Fiore and F. Fioroni and Grana, {C. M.} and E. Grassi and M. Iori and M. Marafini and I. Mattei and S. Morganti and G. Paganelli and V. Patera and A. Pepe and L. Piersanti and L. Recchia and A. Russomando and A. Sarti and A. Sciubba and M. Schiariti and Camillocci, {E. Solfaroli} and A. Versari and C. Voena",
year = "2016",
month = "3",
day = "10",
doi = "10.1109/NSSMIC.2014.7430882",
language = "English",
isbn = "9781479960972",
booktitle = "2014 IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2014",
publisher = "Institute of Electrical and Electronics Engineers Inc.",

}

TY - GEN

T1 - Intraoperative beta- detecting probe for radio-guided surgery of brain tumors

AU - Baroni, G.

AU - Bellini, F.

AU - Bocci, V.

AU - Collamati, F.

AU - Cremonesi, M.

AU - De Lucia, E.

AU - Faccini, R.

AU - Ferroli, P.

AU - Fiore, S.

AU - Fioroni, F.

AU - Grana, C. M.

AU - Grassi, E.

AU - Iori, M.

AU - Marafini, M.

AU - Mattei, I.

AU - Morganti, S.

AU - Paganelli, G.

AU - Patera, V.

AU - Pepe, A.

AU - Piersanti, L.

AU - Recchia, L.

AU - Russomando, A.

AU - Sarti, A.

AU - Sciubba, A.

AU - Schiariti, M.

AU - Camillocci, E. Solfaroli

AU - Versari, A.

AU - Voena, C.

PY - 2016/3/10

Y1 - 2016/3/10

N2 - The innovation of the radio-guided surgery exploiting β- emitters is the higher tumor-to-non-tumor ratio (TNR) allowing both a smaller radiopharmaceutical absorbed dose to detect cancerous remnants and the possibility of extending the technique also to cases with a large uptake of surrounding healthy organs, as for brain tumors. Our first study cases are meningiomas, since an appropriate β- emitting drug is already available (90Y-DOTATOC), but the goal is to apply this technique to gliomas. We verified the uptake of the radiotracer in 8/10 patients affected by meningiomas with TNR ≥ 10 and in 9/12 patients with a TNR ≥ 4 in case of gliomas. We developed prototypes of an intraoperative probe detecting β- radiation. The core of the probe is a millimetric scintillator made of para-terphenyl due to its high light yield and low density. Tests in laboratory showed that with a radiotracer activity on the tumor of 5 kBq/ml and a TNR of 10 a 0.1 ml cancerous residual can be detected in 1s. That corresponds to administer to the patient 1 MBq/kg of radiopharmaceutical, which is a dose comparable to those administered for diagnostic use. Finally we estimated with a detailed simulation the exposure of the surgeon resulted in ∼0.1 Sv/h to the whole body and ∼1 Sv/h to the hands, well below the corresponding values for established RGS with gamma radiation.

AB - The innovation of the radio-guided surgery exploiting β- emitters is the higher tumor-to-non-tumor ratio (TNR) allowing both a smaller radiopharmaceutical absorbed dose to detect cancerous remnants and the possibility of extending the technique also to cases with a large uptake of surrounding healthy organs, as for brain tumors. Our first study cases are meningiomas, since an appropriate β- emitting drug is already available (90Y-DOTATOC), but the goal is to apply this technique to gliomas. We verified the uptake of the radiotracer in 8/10 patients affected by meningiomas with TNR ≥ 10 and in 9/12 patients with a TNR ≥ 4 in case of gliomas. We developed prototypes of an intraoperative probe detecting β- radiation. The core of the probe is a millimetric scintillator made of para-terphenyl due to its high light yield and low density. Tests in laboratory showed that with a radiotracer activity on the tumor of 5 kBq/ml and a TNR of 10 a 0.1 ml cancerous residual can be detected in 1s. That corresponds to administer to the patient 1 MBq/kg of radiopharmaceutical, which is a dose comparable to those administered for diagnostic use. Finally we estimated with a detailed simulation the exposure of the surgeon resulted in ∼0.1 Sv/h to the whole body and ∼1 Sv/h to the hands, well below the corresponding values for established RGS with gamma radiation.

UR - http://www.scopus.com/inward/record.url?scp=84965082645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84965082645&partnerID=8YFLogxK

U2 - 10.1109/NSSMIC.2014.7430882

DO - 10.1109/NSSMIC.2014.7430882

M3 - Conference contribution

AN - SCOPUS:84965082645

SN - 9781479960972

BT - 2014 IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2014

PB - Institute of Electrical and Electronics Engineers Inc.

ER -